The effect of surfactant on clinical outcome of patients with COVID-19
Phase 3
Recruiting
- Conditions
- Mortality of Patients from COVID-19.COVID-19U07.1
- Registration Number
- IRCT20091201002804N12
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
if the patient is intubated and under mechanical ventilation with SpO2<85%
If the patient has confirmed COVID-19
Exclusion Criteria
Coexisting underlying pulmonary disease except for COVID-19
Underlying congenital hear disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time for mechanical ventilation. Timepoint: throughout the study, the time that patient has stayed under mechanical ventilation. Method of measurement: clinical records.
- Secondary Outcome Measures
Name Time Method ICU mortality rate. Timepoint: throughout the study in the ICU ward. Method of measurement: clinical records.